Clinical trial
Compare the Efficacy and Safety of Prednisone Combined With Huaiqihuang Granule Versus Combined With Levamisole for Primary Nephrotic Syndrome in Children: A Prospective, Multi-center, Randomized, Double-blind, Non-inferiority Study
NCT05772871 is registered in ClinicalTrials.gov with Jianhua Zhou as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Compare the Efficacy and Safety of Prednisone Combined With Huaiqihuang Granule Versus Combined With Levamisole for Primary Nephrotic Syndrome in Children: A Prospective, Multi-center, Randomized, Double-blind, Non-inferiority Study
- Lead sponsor
- Jianhua Zhou
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- April 26, 2023
- Completion date
- October 30, 2025
- Enrollment
- 402 (estimated)
- Sites
- 26
Conditions
As the registry lists them; a condition with its own page is linked.
nephrotic syndrome in children